Supplementary Figure S2 from A Phase I and Biodistribution Study of Ifabotuzumab, a Humanized Agonistic EphA3-Targeted Antibody, in Patients with Recurrent Glioblastoma
Hui Gan, Lawrence Cher, Po-ling Inglis, Zarnie Lwin et autres
0 citations
Bryan W. Day
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
218Publications signalées
4451Citations signalées
4Affiliations récentes
Institutions déclarées
Domaines associés
Glioma Diagnosis and TreatmentAxon Guidance and Neuronal SignalingCancer, Hypoxia, and MetabolismNeuroblastoma Research and TreatmentsATP Synthase and ATPases Research
Publications récentes
Supplementary Table S2 from A Phase I and Biodistribution Study of Ifabotuzumab, a Humanized Agonistic EphA3-Targeted Antibody, in Patients with Recurrent Glioblastoma
Hui Gan, Lawrence Cher, Po-ling Inglis, Zarnie Lwin et autres
0 citations
Supplementary Table S1 from A Phase I and Biodistribution Study of Ifabotuzumab, a Humanized Agonistic EphA3-Targeted Antibody, in Patients with Recurrent Glioblastoma
Hui Gan, Lawrence Cher, Po-ling Inglis, Zarnie Lwin et autres
0 citations
Data from A Phase I and Biodistribution Study of Ifabotuzumab, a Humanized Agonistic EphA3-Targeted Antibody, in Patients with Recurrent Glioblastoma
Hui Gan, Lawrence Cher, Po-ling Inglis, Zarnie Lwin et autres
0 citations
Supplementary Figure S1 from A Phase I and Biodistribution Study of Ifabotuzumab, a Humanized Agonistic EphA3-Targeted Antibody, in Patients with Recurrent Glioblastoma
Hui Gan, Lawrence Cher, Po-ling Inglis, Zarnie Lwin et autres
0 citations
Supplementary Table S3 from A Phase I and Biodistribution Study of Ifabotuzumab, a Humanized Agonistic EphA3-Targeted Antibody, in Patients with Recurrent Glioblastoma
Hui Gan, Lawrence Cher, Po-ling Inglis, Zarnie Lwin et autres
0 citations
A Phase I and Biodistribution Study of Ifabotuzumab, a Humanized Agonistic EphA3-Targeted Antibody, in Patients with Recurrent Glioblastoma
Hui Gan, Lawrence Cher, Po-ling Inglis, Zarnie Lwin et autres
0 citationsClinical Cancer Research
Abstract A056: Growth rates of patient-derived tumor organoids reflect heterogeneity in tumor plasticity among glioblastoma patients
Guillermo A. Gomez, Kaitlin G. Scheer, Erica C. F. Yeo, Chloé Shard et autres
0 citationsCancer Research
Monitoring glioblastoma extracellular vesicle evolution using a nanodiagnostic platform to detect glioma stem cells driving recurrent disease
Zhen Zhang, Richard J. Lobb, Paul A. Tooney, Jing Wang et autres
4 citationsScience Advances
Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma
George Joun, Emma G. Kempe, Brianna Chen, Jayden Sterling et autres
6 citationsNature Communications
Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
Evangeline R. Jackson, Ryan J. Duchatel, Dilana E. Staudt, Mika L. Persson et autres
0 citations
Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
Evangeline R. Jackson, Ryan J. Duchatel, Dilana E. Staudt, Mika L. Persson et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.